.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Novartis
Covington
Moodys
McKesson
Healthtrust
AstraZeneca
Federal Trade Commission
QuintilesIMS
Boehringer Ingelheim

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050356

« Back to Dashboard
NDA 050356 describes COLY-MYCIN S, which is a drug marketed by Parke Davis and Endo Pharms Inc and is included in two NDAs. It is available from three suppliers. Additional details are available on the COLY-MYCIN S profile page.

The generic ingredient in COLY-MYCIN S is colistin sulfate; hydrocortisone acetate; neomycin sulfate; thonzonium bromide. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colistin sulfate; hydrocortisone acetate; neomycin sulfate; thonzonium bromide profile page.

Summary for NDA: 050356

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 050356

Suppliers and Packaging for NDA: 050356

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COLY-MYCIN S
colistin sulfate; hydrocortisone acetate; neomycin sulfate; thonzonium bromide
SUSPENSION/DROPS;OTIC 050356 NDA Par Pharmaceutical, Inc. 42023-109 42023-109-01 10 mL in 1 BOTTLE, DROPPER (42023-109-01)
COLY-MYCIN S
colistin sulfate; hydrocortisone acetate; neomycin sulfate; thonzonium bromide
SUSPENSION/DROPS;OTIC 050356 NDA Physicians Total Care, Inc. 54868-0564 54868-0564-0 10 mL in 1 BOTTLE, DROPPER (54868-0564-0)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION/DROPS;OTICStrengthEQ 3MG BASE/ML;10MG/ML;EQ 3.3MG BASE/ML;0.5MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Daiichi Sankyo
UBS
US Department of Justice
Merck
Healthtrust
Cipla
Chubb
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot